The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 11, 2014
Filed:
Mar. 18, 2011
Mary Faris, Los Angeles, CA (US);
Pia M. Challita-eid, Encino, CA (US);
Rene S. Hubert, Los Angeles, CA (US);
Daniel E. H. Afar, Short Hills, NJ (US);
Arthur B. Raitano, Los Alamitos, CA (US);
Wangmao GE, Tampa, FL (US);
Robert Kendall Morrison, Santa Monica, CA (US);
Karen Jane Meyrick Morrison, Santa Monica, CA (US);
Aya Jakobovits, Beverly Hills, CA (US);
Mary Faris, Los Angeles, CA (US);
Pia M. Challita-Eid, Encino, CA (US);
Rene S. Hubert, Los Angeles, CA (US);
Daniel E. H. Afar, Short Hills, NJ (US);
Arthur B. Raitano, Los Alamitos, CA (US);
Wangmao Ge, Tampa, FL (US);
Robert Kendall Morrison, Santa Monica, CA (US);
Karen Jane Meyrick Morrison, Santa Monica, CA (US);
Aya Jakobovits, Beverly Hills, CA (US);
Agensys, Inc., Santa Monica, CA (US);
Abstract
A novel gene (designated 125P5C8) and its encoded protein, and variants thereof, are described wherein 125P5C8 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 125P5C8 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 125P5C8 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 125P5C8 can be used in active or passive immunization.